Literature DB >> 7526222

Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene.

E Araki1, M A Lipes, M E Patti, J C Brüning, B Haag, R S Johnson, C R Kahn.   

Abstract

The principal substrate for the insulin and insulin-like growth factor-1 (IGF-1) receptors is the cytoplasmic protein insulin-receptor substrate-1 (IRS-1/pp185). After tyrosine phosphorylation at several sites, IRS-1 binds to and activates phosphatidylinositol-3'-OH kinase (PI(3)K) and several other proteins containing SH2 (Src-homology 2) domains. To elucidate the role of IRS-1 in insulin/IGF-1 action, we created IRS-1-deficient mice by targeted gene mutation. These mice had no IRS-1 and showed no evidence of IRS-1 phosphorylation or IRS-1-associated PI(3)K activity. They also had a 50 per cent reduction in intrauterine growth, impaired glucose tolerance, and a decrease in insulin/IGF-1-stimulated glucose uptake in vivo and in vitro. The residual insulin/IGF-1 action correlated with the appearance of a new tyrosine-phosphorylated protein (IRS-2) which binds to PI(3)K, but is slightly larger than and immunologically distinct from IRS-1. Our results provide evidence for IRS-1-dependent and IRS-1-independent pathways of insulin/IGF-1 signalling and for the existence of an alternative substrate of these receptor kinases.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7526222     DOI: 10.1038/372186a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  316 in total

1.  Exercise-induced changes in expression and activity of proteins involved in insulin signal transduction in skeletal muscle: differential effects on insulin-receptor substrates 1 and 2.

Authors:  A V Chibalin; M Yu; J W Ryder; X M Song; D Galuska; A Krook; H Wallberg-Henriksson; J R Zierath
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

Review 2.  Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance.

Authors:  A Virkamäki; K Ueki; C R Kahn
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

Review 3.  Signaling pathways in insulin action: molecular targets of insulin resistance.

Authors:  J E Pessin; A R Saltiel
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

Review 4.  Insights into insulin resistance and type 2 diabetes from knockout mouse models.

Authors:  T Kadowaki
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

Review 5.  Tissue-specific targeting of the insulin receptor gene.

Authors:  Rohit N Kulkarni; Terumasa Okada
Journal:  Endocrine       Date:  2002-12       Impact factor: 3.633

6.  Hyperinsulinemia, glucose intolerance, and dyslipidemia induced by acute inhibition of phosphoinositide 3-kinase signaling in the liver.

Authors:  Kazuaki Miyake; Wataru Ogawa; Michihiro Matsumoto; Takehiro Nakamura; Hiroshi Sakaue; Masato Kasuga
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

7.  The conserved phosphoinositide 3-kinase pathway determines heart size in mice.

Authors:  T Shioi; P M Kang; P S Douglas; J Hampe; C M Yballe; J Lawitts; L C Cantley; S Izumo
Journal:  EMBO J       Date:  2000-06-01       Impact factor: 11.598

8.  A point mutation in the UDP-glucose pyrophosphorylase gene results in decreases of UDP-glucose and inactivation of glycogen synthase.

Authors:  Juan-Carlos Higuita; Alberto Alape-Girón; Monica Thelestam; Abram Katz
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

9.  Insulin receptor substrate 2 (IRS2)-deficient mice show sensorineural hearing loss that is delayed by concomitant protein tyrosine phosphatase 1B (PTP1B) loss of function.

Authors:  Silvia Murillo-Cuesta; Guadalupe Camarero; Agueda González-Rodríguez; Lourdes Rodríguez De La Rosa; Deborah J Burks; Carlos Avendaño; Angela M Valverde; Isabel Varela-Nieto
Journal:  Mol Med       Date:  2012-03-30       Impact factor: 6.354

Review 10.  Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms.

Authors:  Shaodong Guo
Journal:  J Endocrinol       Date:  2014-01-08       Impact factor: 4.286

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.